Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | 8.92 Bn |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | 1.08 Bn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 505.90 Mn |
| 10 | Amylyx Pharmaceuticals | 3.91 Bn | 3.91 Bn | - | 111.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 111.20 Mn |
| Mar 31, 2026 | 110.56 Mn |
| Dec 31, 2025 | 94.57 Mn |
| Sep 30, 2025 | 93.33 Mn |
| Jun 30, 2025 | 89.14 Mn |
| Mar 31, 2025 | 85.70 Mn |
| Dec 31, 2024 | 68.14 Mn |
| Sep 30, 2024 | 68.09 Mn |
| Jun 30, 2024 | 68.02 Mn |
| Mar 31, 2024 | 67.85 Mn |
| Dec 31, 2023 | 69.99 Mn |
| Sep 30, 2023 | 69.75 Mn |
| Jun 30, 2023 | 70.13 Mn |
| Mar 31, 2023 | 70.86 Mn |
| Dec 31, 2022 | 58.50 Mn |
| Sep 30, 2022 | 58.53 Mn |
| Jun 30, 2022 | 58.28 Mn |
| Mar 31, 2022 | 51.60 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 6.76 Mn |